| ORIGINAL ARTICLE |
|
| Year : 2010 | Volume
: 2
| Issue : 2 | Page : 86-88 |
|
|
Bimatoprost in the treatment of eyelash universalis alopecia areata
Teresa Ojeda Vila, Francisco M Camacho Martinez
Universital Hospital Virgen Macarena, Sevilla, Spain
Correspondence Address:
Teresa Ojeda Vila
Av. Dr. Fedriani s/n, 41009, Sevilla
Spain
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0974-7753.77511
|
|
|
Objectives: To evaluate topical bimatoprost for eyelash growth in patients with alopecia areata (AA). Design: A 1-year retrospective study, bilateral eyelash alopecia. Materials and Methods: Forty-one subjects with AA universalis without ocular disease applied 0.03% bimatoprost to the eyelid margin once a day over the course of 1 year. Results: Thirty-seven subjects completed the study, one patient was eliminated due to conjunctivitis at the beginning of treatment, two patients developed conjunctivitis after 6 months of treatment, and a fourth did not follow directions. Researchers evaluated patients' eyelash growth every 4 months. We observed complete growth in 24.32%, moderate growth in 18.91%, slight growth in 27.02% and without response in 29.72%. Conclusion: Bimatoprost may be effective and safe in the treatment of eyelash AA. 43.24% of the patients had an acceptable cosmetic response (total and moderate growth). Limitations: Design without control. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
